Prevalence of fecal carriage of antibiotic-resistant bacteria in patients with acute surgical abdominal infections

References

• Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med 2003;31:2228–37.
   PubMed Web of Science ®Google Scholar
• Barie PS. Serious intra-abdominal infections. Curr Opin Crit Care 2001;7:263–7.
   PubMedGoogle Scholar
• McClean KL, Sheehan GJ, Harding GK. Intraabdominal infection: a review. Clin Infect Dis 1994;19:100–16.
   PubMed Web of Science ®Google Scholar
• Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, Lauwers P. Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 2003;27:379–84.
   PubMed Web of Science ®Google Scholar
• Berger D, Buttenschoen K. Management of abdominal sepsis. Langenbecks Arch Surg 1998;383:35–43.
   PubMed Web of Science ®Google Scholar
• Pine RW, Wertz MJ, Lennard ES, Dellinger EP, Carrico CJ, Minshew BH. Determinants of organ malfunction or death in patients with intra-abdominal sepsis. A discriminant analysis. Arch Surg 1983;118:242–9.
   PubMedGoogle Scholar
• Nathens AB, Rotstein OD, Marshall JC. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg 1998;22:158–63.
   PubMed Web of Science ®Google Scholar
• Pitcher WD, Musher DM. Critical importance of early diagnosis and treatment of intra-abdominal infection. Arch Surg 1982;117:328–33.
   PubMedGoogle Scholar
• Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996;23:486–94.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Barefoot L, Griffith J, Ruthazar R, Snydman DR. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis 1996;15:913–21.
   PubMed Web of Science ®Google Scholar
• Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M. Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 1996;131:1193–201.
   PubMedGoogle Scholar
• Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206–12.
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162–71.
   PubMed Web of Science ®Google Scholar
• Ariffin H, Navaratnam P, Mohamed M, Arasu A, Abdullah WA, Lee CL, Peng LH. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int J Infect Dis 2000;4:21–5.
   PubMedGoogle Scholar
• Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:1065–78.
   PubMedGoogle Scholar
• Torell E. Epidemiology of enterococci with acquired resistance to antibiotics in Sweden: special emphasis on ampicillin and vancomycin. Uppsala: Acta Universitatis Upsaliensis; 2003.
   Google Scholar
• Arpin C, Rogues AM, Kabouche S, Boulard G, Quesnel C, Gachie JP, Quentin C. Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a neurosurgical intensive care unit. Epidemiol Infect 2000;124:401–8.
   PubMed Web of Science ®Google Scholar
• Roghmann MC, McCarter RJ Jr, Brewrink J, Cross AS, Morris JG Jr. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis 1997;25:1056–9.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008;62:1142–9.
   PubMed Web of Science ®Google Scholar
• Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007;51:2720–5.
   PubMed Web of Science ®Google Scholar
• Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007;28:1114–16.
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 2006;42:925–34.
   PubMed Web of Science ®Google Scholar
• Miro E, Mirelis B, Navarro F, Rivera A, Mesa RJ, Roig MC, Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain. J Antimicrob Chemother 2005;56:1152–5.
   PubMed Web of Science ®Google Scholar
• Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004;42:4769–75.
   PubMed Web of Science ®Google Scholar
• SMI. http://www.smi.se/statistik/vancomycinresistenta-entrokocker-vre.
   Google Scholar
• Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. Apmis 2008;116:302–8.
   PubMed Web of Science ®Google Scholar
• Naseer U, Natas OB, Haldorsen BC, Bue B, Grundt H, Walsh TR, Sundsfjord A. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. Apmis 2007;115:120–6.
   PubMed Web of Science ®Google Scholar
• Fang H, Lundberg C, Olsson-Liljequist B, Hedin G, Lindback E, Rosenberg A, Struwe J. Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum beta-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J Clin Microbiol 2004;42:5917–20.
   PubMed Web of Science ®Google Scholar
• Hallgren A, Saeedi B, Nilsson M, Monstein HJ, Isaksson B, Hanberger H, Nilsson LE. Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units. J Antimicrob Chemother 2003;52:162–7.
   PubMed Web of Science ®Google Scholar
• Torell E, Cars O, Hambraeus A. Ampicillin-resistant enterococci in a Swedish university hospital: nosocomial spread and risk factors for infection. Scand J Infect Dis 2001;33:182–7.
   PubMedGoogle Scholar
• Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, Wolff M. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 2001;48:161–76.
   PubMed Web of Science ®Google Scholar
• SWEDRES 2008. www.strama.se.
   Google Scholar
• EARSS. EARSS, www.rivm.nl/earss.
   Google Scholar
• Hopkins JA, Wilson SE, Bobey DG. Adjunctive antimicrobial therapy for complicated appendicitis: bacterial overkill by combination therapy. World J Surg 1994;18:933–8.
   PubMedGoogle Scholar
• Mosdell DM, Morris DM, Fry DE. Peritoneal cultures and antibiotic therapy in pediatric perforated appendicitis. Am J Surg 1994;167:313–16.
   PubMed Web of Science ®Google Scholar
• Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, Antibiotic treatment for surgical peritonitis. Ann Surg 1991;214:543–9.
   PubMed Web of Science ®Google Scholar
• Dominguez EA, Smith TL, Reed E, Sanders CC, Sanders WE Jr. A pilot study of antibiotic cycling in a hematology-oncology unit. Infect Control Hosp Epidemiol 2000;21(1 Suppl):S4–8.
   Google Scholar
• Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000;21:455–8.
   PubMed Web of Science ®Google Scholar
• Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998;280:1233–7.
   PubMed Web of Science ®Google Scholar
• Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:53–8.
   PubMed Web of Science ®Google Scholar
• Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118–24.
   PubMed Web of Science ®Google Scholar
• Hollander R, Ebke M, Barck H, von Pritzbuer E. Asymptomatic carriage of Klebsiella pneumoniae producing extended-spectrum beta-lactamase by patients in a neurological early rehabilitation unit: management of an outbreak. J Hosp Infect 2001;48:207–13.
   PubMed Web of Science ®Google Scholar
• SWEDRES 2005. www.strama.se.
   Google Scholar
• Dinubile MJ, Friedland I, Chan CY, Motyl MR, Giezek H, Shivaprakash M, Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 2005;24:443–9.
   PubMed Web of Science ®Google Scholar
• Asensio A, Oliver A, Gonzalez-Diego P, Baquero F, Perez-Diaz JC, Ros P, Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000;30:55–60.
   PubMed Web of Science ®Google Scholar
• Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–8.
   PubMed Web of Science ®Google Scholar